Table 2. Association between log of klotho concentration and several health statuses (pg/mL).
N | Unadjusted Model | Adjusted Model 1a | Adjusted Model 2b | Adjusted Model 3c | Adjusted Model 4d | |||||||||||
Beta | SE | p-value | Beta | SE | p-value | Beta | SE | p-value | Beta | SE | p-value | Beta | SE | p-value | ||
Uric acid | ||||||||||||||||
Per one-unit increase | 11734 | −0.034 | 0.003 | <.0001* | −0.034 | 0.004 | <.0001* | −0.034 | 0.004 | <.0001* | −0.033 | 0.003 | <.0001* | −0.028 | 0.004 | <.0001* |
Hyperuricemia | ||||||||||||||||
No | 9092 | Reference | Reference | Reference | Reference | Reference | ||||||||||
Yes | 2642 | −0.085 | 0.009 | <.0001* | −0.08 | 0.009 | <.0001* | −0.079 | 0.009 | <.0001* | −0.075 | 0.009 | <.0001* | −0.062 | 0.009 | <.0001* |
History of gout | ||||||||||||||||
No | 11031 | Reference | Reference | Reference | Reference | Reference | ||||||||||
Yes | 703 | −0.074 | 0.021 | 0.0006* | −0.054 | 0.012 | 0.0089* | −0.049 | 0.02 | 0.0176* | −0.046 | 0.02 | 0.0237* | −0.039 | 0.019 | 0.0443* |
Hyperuricemia in the group with a history of gout | ||||||||||||||||
No | 386 | Reference | Reference | Reference | Reference | Reference | ||||||||||
Yes | 317 | −0.072 | 0.026 | 0.0059* | −0.067 | 0.027 | 0.0141* | −0.073 | 0.029 | 0.0148* | −0.07 | 0.031 | 0.0258* | −0.043 | 0.030 | 0.1462 |
aModel 1: Adjusted for age, gender, ethnicity. bModel 2: Model 1 + Adjusted for disease history (history of diabetes, hypertension, kidney disease, and malignancy). cModel 3: Model 2 + Adjusted for education, family income, exercise, alcohol, smoking, and obesity. dModel 4: Model 3 + Adjusted for kidney function(eGFR). *p < 0.05.